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Summary The tissues of hepatocellular carcinoma were operatively resected from six patients. All four
components of the systems of microsomal cytochrome P-450-linked monooxygenase of the tissues were
investigated and compared to those of normal liver tissue. The concentrations of cytochromes P-450, P-420
and b5 were measured optically and the concentrations of all components except cytochrome P-450 were
measured by the Western blotting method followed by immunochemical staining. In microsomes of
hepatocellular carcinoma tissues, there was as much cytochrome P-450 and other redox components as in the
normal liver tissues, but cytochrome P-450 in liver cancer tissues was unstable and easily converted to
cytochrome P-420. The specific activities of NADPH- and NADH-ferricyanide and cytochrome c reductase of
each sample were also measured. In the microsomes of the cancer tissues, the specific activities were
remarkably reduced compgared with those of normal liver tissues. The lipid compositions of the microsomes
and the phospholipid/cholesterol ratios (w/w) were 13.1 +3.13 in the cancer tissues and 43.0+6.74 in normal
liver tissues. This difference of the lipid composition elucidates the instability of cytochrome P-450 molecules
and the inefficiency of the electron transport of cytochrome P-450-linked monooxygenase systems.
The microsomal cytochrome P-450-linked monooxygenase
system of the liver is important in drug metabolism (Cooper
et al., 1965) and carcinogenesis (Norman et al., 1979). The
system contains five components: NADPH-cytochrome P-
450 reductase, NADPH-cytochrome b5 reductase, cyto-
chrome b5, desaturase and cytochrome P-450 (lyanagi &
Mason, 1973; Hrycay & Prough, 1974). In human liver
microsomes, there are multiple molecular forms of cyto-
chrome P-450, some of which have been isolated and
purified (Wrighton et al., 1986; Wang et al., 1983).
Although considerable information is available about the
influence of chemically induced hyperplastic tumours on
drug-metabolising enzymes in laboratory animals (Eriksson
et al., 1983; Astrom et al., 1983), there is little information
on changes in these enzymes induced in human liver by
neoplasia such as hepatocellular carcinoma. In the preneo-
plastic stage of chemically induced hepatic nodules of rats,
these drug-oxidising enzymes are decreased (Farbe, 1984),
but in human hepatic neoplasms there is no report on the
enzyme molecules of the microsomal cytochrome P-450-
linked monooxygenase systems except for their activities (El
Mouelhi et al., 1987).
The absorption at 450nm of reduced cytochrome P-450
under carbon monoxide is unusual among the known b-type
cytochromes, but the electron paramagnetic resonance
absorption of this cytochrome is typical and easily detectable
(Mason et al., 1965). Some workers have reported the
electron paramagnetic resonance spectra of the high-spin or
low-spin forms of cytochrome P-450 in microsomes or
purified cytochromes P-450 of animals (Ichikawa &
Yamano, 1970; Ichikawa et al., 1967). No electron paramag-
netic resonance spectrum of the intact tissues of normal
human liver or hepatic neoplasm has been reported. The
electron paramagnetic resonance spectra of normal liver and
hepatocellular carcinoma tissues of humans were measured.
In many species, the lipid compositions of hepatic micro-
somes have been measured to predict the properties of the
lipid bilayers; the molar ratios of phospholipid to cholesterol
in human liver microsomes have been estimated to be 14.5
(Waskell et al., 1982) and 7.5 (Kapitulnik et al., 1987), and
the weight ratio to be 30.9 (Benga et al., 1983). But the
relationship between the change of the lipid composition and
carcinogenesis has not been clarified.
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Materials and methods
Subjects
A total of nine liver specimens were obtained from patients
of hepatocellular carcinoma at the time of operation at the
department of surgery of Kagawa Medical School. Of the
nine resected livers bearing hepatocellular carcinoma, three
cancer tissues were not available for analysis because of the
tissue necrosis. Five normal livers used as controls were
obtained by liver biopsy for suspected disease during abdo-
minal surgery, and had a normal histological appearance.
Nine tissue regions distant from the cancer tissues in the
resected livers with a normal histological appearance were
also used as tissues of 'distant regions'. All liver tissues were
immediately frozen in liquid nitrogen and stored at -80°C.
The maximum time between removal of the biopsy sample
and its being frozen did not exceed 20min. These tissue
samples were classified into three groups: cancer tissues,
tissues of distant regions and normal tissues.
Chemicals
IgG fractions of peroxidase-conjugated sheep anti-chicken
IgG were purchased from Cappel Laboratories Inc. Bovine
serum albumin was purchased from Boehringer Mannheim
Inc. A protein assay kit was purchased from Bio-Rad
Laboratories. Cellulose nitrate paper (pore size, 0.45,um) was
purchased from Toyo Roshi Co. Ltd. Acrylamide, bis-
acrylamide and sodium dodecyl sulphate were purchased
from Nakarai Chemicals Ltd. The other chemicals were
purchased from Wako Pure Chemical Industries. These
chemicals were of the highest quality commercially available.
Standard phospholipids were purchased from Serdary
Research Laboratories. A cholesterol C-test kit was
purchased from Wako Pure Chemical Industries.
Preparation of microsomes
Liver tissues or cancer tissues were homogenised with a
Teflon homogeniser in 0.25M sucrose, and the pH was
adjusted to 7.4 with 1.0M Tris. The homogenates were
centrifuged at 8,000g for 10min at 4°C. The supernatants
were again centrifuged at 105,000g for 60min at 4°C. The
precipitates were homogenised in 1.15% potassium chloride,
pH 7.4, with a Teflon homogeniser and centrifuged at
105,000g for 90min to remove contaminating haemoglobin.
The precipitates were stored at -80°C and used as micro-
somal pellets. The microsomes were suspended in 0.1 M
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potassium phosphate buffer, pH 7.4, and were used as
microsomal suspensions.
Protein concentrations
Protein concentrations were measured by the method of
Bradford with a protein assay kit (Bradford, 1976).
Enzyme preparations
Cytochrome b5, NADPH-cytochrome P-450 reductase and
NADH-cytochrome b5 reductase of bovine liver microsomes
were purified by the methods of Spatz & Strittmatter
(1973). These enzymes were electrophoretically pure and
each gave a single protein band on SDS-polyacrylamide gel
electrophoresis.
SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide gel electrophoresis was done by the
method of Laemmli (1970). The purified cytochrome b5,
NADPH-cytochrome P-450 reductase and NADH-
cytochrome b5 reductase from bovine liver microsomes were
measured spectrophotometrically with the molar extinction
coefficients of 163.0mm-v1 cm-1 at 424nm (Spatz &
Strittmatter, 1973), 21.4mM-1 cm-1 at 454nm (Oprian &
Coon, 1982), and 10.2mM-1 cm-l at 460nm (Spatz &
Strittmatter, 1973), respectively.
Antisera preparations
Chicken anti-bovine cytochrome b5, NADPH-cytochrome
P-450 reductase and NADH-cytochrome b5 reductase were
prepared by the method of Hamamoto et al. (1986).
Analytical procedures
Microsomes were suspended in 0.1 M potassium phosphate
buffer, pH 7.4 to the protein concentration of 1.0mgml-1.
The concentrations of cytochromes P-450 and P-420 of each
suspension were measured from the difference spectra of
sodium dithionite-reduced samples, with a value of
91 m- cm-I assumed for the molar extinction increment
between 450 and 490 nm for cytochrome P-450 (Omura &
Sato, 1964a) and a value of 110 M- cm - assumed for
between 420 and 490 nm for cytochrome P-420 (Omura &
Sato, 1964b). In the measurement of the difference spectra,
both sample and reference cuvets were bubbled with carbon
monoxide to cancel the absorption peak derived from conta-
minated deoxyhaemoglobin, followed by reduction of the
sample cuvet with sodium dithionite. By this method, the
absorption of deoxyhaemoglobin can be cancelled, but
methaemoglobin cannot be. To estimate the content of
methaemoglobin in each tissue, the difference spectra were
measured as follows: the sample and reference cuvets were
bubbled with mixed gas of carbon monoxide and oxygen
(CO:O2=1:1 (v/v)) and the sample cuvet was reduced with
sodium dithionite. In this difference spectrum, the absorption
peak at 420 nm was that of methaemoglobin.
The concentrations of cytochrome b5 in microsomal sus-
pensions were measured by the absorbance difference of
424-409 nm in the difference spectra of NADH-reduced
sample minus an air-saturated sample with the molar extinc-
tion coefficient 185 Mm-1 cm - 1 (424-409 nm) by the method
of Omura and Sato (1964a,b).
The cytochrome b5, NADPH-cytochrome P-450 reductase
and NADH-cytochrome b5 reductase of the microsomes
were measured by the Western blotting method followed by
immunochemical staining by the method of Hamamoto et al.
(1986).
Activities of NADPH- and NADH-ferricyanide and
NADPH- and NADH-cytochrome c reductase of each
microsome sample were measured by the method of Hiwa-
tashi et al. (1976).
Electron paramagnetic resonance (EPR) spectrum
Portions of frozen tissues 2.2mm across and 3cm thick were
punched out with a stainless steel tube. Each sample was put
on the top of a quartz EPR tube with an inner diameter of
2.5mm, which was filled with saline at room temperature
and preintubed with a fine silicon tube connected with an
injector (10ml). Withdrawal of the piston moved the
punched out sample to the bottom of the EPR tube in place
of the saline. The EPR tube loaded with sample was frozen
slowly from the bottom with liquid nitrogen and set in a
JEOL Ltd EPR spectrophotometer. All EPR spectra were
recorded in a first derivative display at a microwave power
level below saturation. Electron paramagnetic resonance
spectra were measured with a JEOL Ltd EPR spectrophoto-
meter model JES-RE2X with an Air Products Ltd LTR-3-
110 liquid helium cryostat and a JEOL Ltd data processor
model ES-PRIT2.
High-pressure liquid chromatography (HPLC)
High-pressure liquid chromatography was done with a Toyo
Soda liquid chromatographic system consisting of a Model
CCPM pump and Model UV-8000 ultraviolet detector with
a data processor Chromatocorder 11 from System Instru-
ments Co. For phospholipid chromatography, the wave-
length of the detector was set at 210nm. Phospholipid
separation was achieved with a Toyo Soda 4.6 x 250mm
column packed with TSK gel Silica-60 at room temperature.
For routine phospholipid separations, the lipid extract was
put on the column and a solvent system of acetonitrile-
methanol-phosphate 900:95:5 (v/v/v) was used. The solvent
mixture was delivered by the pump at a flow rate of
1.0mlmin-1.
Measurement of microsomal lipid composition
Phospholipid analysis Lipid extraction was done by the
method of Folch et al. (1957). Briefly, 0.1 ml of microsomal
suspension containing 0.5mg of protein was suspended in
0.9ml of a 2:1 chloroform-methanol mixture (v/v) and
thoroughly mixed with a vortex mixer for 3min. The
suspensions were centrifuged at 2,000g for 10min to remove
the denatured proteins, and the supernatants were collected.
These crude extracts were mixed thoroughly with 0.2
volumes of distilled water. The mixtures were centrifuged at
2,000g for 10min again. The upper phase was removed as
quickly as possible, This washing procedure was repeated
three times and the lower phases and the remaining rinsing
fluids were put into one phase by the addition of 0.1 ml of
methanol. These extracts were filtered with an Acro LC13
filter from Gelman Sciences Inc. Phospholipids in the solu-
tions were analysed by HPLC by the method of Kaduce et
al. (1983) with minor modifications.
Cholesterol analysis A microsome pellet (5mg of protein)
was suspended in 1 ml of 0.1 M potassium phosphate buffer,
pH 7.4, containing 0.1% phenol and 0.3% cholic acid. This
mixture was incubated for 30min at room temperature. The
cholesterol concentration of this mixture was measured with
a Cholesterol C-test kit by the improved method of
Barenholz et al. (1978).
Results
Concentrations of cytochromes b5, P-450 and P-420 in
hepatocellular carcinoma
The concentrations of cytochromes b5, P-450 and P-420 of
microsomes of human hepatocellular carcinoma and normal
liver tissues were measured spectrophotometrically (Table I).
These results indicate that the regions distant from the
cancer nodules had cytochromes b5, P-450 and P-420 at
levels comparable to those in normal liver tissues. Even in8 I. HAMAMOTO et al.
Table I Concentrations of cytochromes b5, P-450 and P-420 determined by
spectrophotometry
HCC Non-cancer region Normal liver
(n=6) (n=9) (n=5)
b5 (nmol per mg protein) 0.018+0.026a 0.127+0.047 0.145+0.023
P-450 (nmol per mg protein) 0.024+0.03a 0.138+0.068 0.199+0.043
P-420 (nmol per mg protein) 0.106+0.056a 0.030+0.048 0.018+0.019
P-450+P-420 (nmol per mg protein) 0.130+0.081 0.168+0.072 0.217+0.024
P-450/(P-450+P-420) (%) 14.0+ 12.3a 84.7+21.6 91.0+9.74
HCC, hepatocellular carcinoma; + indicates the standard deviation. 2Statistically
different from the values of normal liver at P<0.01.
Table II NADPH- and NADH-ferricyanide and cytochrome c reductase activities
HCC Non-cancer region Normal liver
(n=6) (n=9) (n=5)
NADH-ferricyanide reductase activity (umol per mg protein per min) 1.12+0.32 1.39+0.21 1.60+0.071
NADPH-ferricyanide reductase activity (imol per mg protein per min) 0.56+0.057 0.62+0.072 0.68+0.11
NADH-cytochrome c reductase activity (nmol per mg protein per min) 44.7+ 52.9a 118.4+50.2 157.0+14.1
NADPH-cytochrome c reductase activity (nmol per mg protein per min) 10.5 + 8.6a 27.3+39.0 33.2+8.3
HCC, hepatocellular carcinoma; + indicates the standard deviation. 'Statistically different from the values of normal liver at
P<0.01.
the hepatocellular carcinoma tissue, the sum of cytochromes
P-450 and P-420 are similar to those in normal livers or
distant regions. But in hepatocellular carcinoma, the ratios
of cytochrome P-450 to the sum of cytochromes P-450 and
P-420 are smaller than for other samples. It is known that
the affinity of haemoglobin to carbon monoxide is much
stronger than that of cytochrome P-450 (Ichikawa et al.,
1967). In the measurement of the difference spectra using the
mixed gas of carbon monoxide and oxygen, the purified
cytochrome P-450 was not bound to carbon monoxide
whereas haemoglobin was bound. Using this result, concen-
trations of contaminated methaemoglobin of the microsomal
suspensions were measured and the contents of contaminated
methaemoglobin were negligible compared to those of
cytochrome P-420 (data not shown). So, the absorption peak
at 420nm of the carbon monoxide-difference spectrum was
looked upon as that of cytochrome P-420.
The concentrations of cytochrome b5 in the cancer tissues
were also decreased to about one-eighth those in normal
liver tissues or distant regions of the cancers.
Specific activities of NADPH- or NADH-ferricyanide
reductase, cytochrome c reductase and cytochrome P-450
reductase
Table II shows the activities of NADPH- and NADH-
ferricyanide reductase and NADPH- and NADH-
cytochrome c reductase of the microsomal preparations. The
results indicate that the activities of NADPH- or NADH-
ferricyanide reductase were almost the same for the three
groups. On the other hand, NADPH- or NADH-cytochrome
c reductase activities were higher in normal livers or distant
regions than in hepatocellular carcinoma tissues. These find-
ings suggest that in microsomes from the cancer, the electron
can be easily transferred to ferricyanide, but it is difficult for
macromolecules such as cytochrome c.
Measurement of cytochrome b5, NADPH-cytochrome b5
reductase and NADPH-cytochrome P-450 reductase by
Western blotting
NADPH- and NADH-cytochrome c reductase activities were
low in hepatocellular carcinoma tissues for two possible
reasons: a decrease in the concentrations of cytochrome b5,
NADPH-cytochrome P-450 reductase or NADH-cytochrome
b5 reductase in cancer tissues, or low efficiency of electron
transport from NADH or NADPH to cytochrome c via
NADH-cytochrome b5 reductase. The concentrations of
cytochrome b5, NADH-cytochrome b5 reductase and
NADPH-cytochrome P-450 reductase were measured
immunochemically. Figure 1 shows the immunochemicall)
stained cellulose nitrate papers of typical tissues stained witk
antibodies of cytochrome b5, NADH-cytochrome b5 reduc-
tase and NADPH-cytochrome P-450 reductase. The results
are summarised in Table III, which shows that the concen
trations and the molecular weights of the three components
are almost the same for all microsomal samples. Thiz
supports the second possibility.
1 2 3 4 5
a
b
c
......
... ...
Figure 1 Enzyme bands of the typical cancer tissues on cellulose
nitrate papers stained with antibodies to cytochrome b5, NADH-
cytochrome b5 reductase and NADPH-cytochrome P-450 reduc-
tase, respectively. Each well contained 0.5 mg of proteins of
microsomes of cancer and normal tissues. (a) Stained with rabbit
anti-bovine cytochrome b5; (b) stained with chicken anti-bovine
NADH-cytochrome b5 reductase; (c) stained with chicken anti-
bovine NADPH-cytochrome P-450 reductase. 1,2, normal liver
tissues; 3-5, hepatocellular carcinoma tissues.HUMAN HEPATOCELLULAR CARCINOMA 9
Table III Concentrations of cytochrome b5, NADH-cytochrome b5 reductase and NADPH-
cytochrome P-450 reductase by Western blotting method followed by immunochemical staining
HCC Non-cancer region Normal liver
(n=6) (n=9) (n=S)
b5 (pmol per protein) 14.1+6.3 24.0+8.5 11.6+4.3
b5 reductase (pmol per mg protein) 19.4+10.5 28.2+7.8 28.1+12.3
P-450 reductase (pmol per mg protein) 120.2+42.8 133.0+46.2 187.9+56.2
HCC, hepatocellular carcinoma, + indicates the standard deviation.
Table IV Phospholipids and cholesterol compositions measured by high pressure liquid
chromatography
HCC Non-cancer region Normal liver
(n=6) (n=9) (n=5)
Phospholipids (ug per mg protein) 89.8+36.1 104.1 +34.2 105.5+3.7
Phosphatidyl choline 27.0+9.7a 46.4+20.6 51.9+13.9
Phosphatidyl ethanolamine 19.3+11.8 27.1 +11.9 31.0+14.3
Phosphatidyl inositol 15.3 +2.63 14.8+4.0 17.3 +3.31
Phosphatidyl serine 28.3+24.8 15.7+ 12.0 5.38+0.01
Cholesterols (ug per mg protein) 7.08+3.22a 4.64+ 1.39a 2.49+0.48
Phospholipid/cholesterol 13.1 +3.13a 23.1 +8.42a 43.0+6.74
HCC, hepatocellular carcinoma; + indicates the standard deviation. aStatistically
different from the values of normal liver at P<0.05.
Lipid compositions of the microsomes
The lipid compositions of the prepared microsomes of
normal and cancer liver tissues were analysed by HPLC.
Phospholipid compositions, cholesterol concentrations and
phospholipid/cholesterol ratios of microsomes of the three
groups are listed in Table IV. This table indicates that
phosphatidyl choline was decreased and cholesterols were
increased in the cancer tissues compared with the tissues of
distant region or normal liver, so the phospholipid/
cholesterol ratios were decreased to 13.1 (w/w) in cancer
microsomes. In the distant region from the cancer nodule,
only cholesterols were increased and the phospholipid/
cholesterol ratios were slightly decreased.
Discussion
The cytochrome P-450-linked monooxygenase systems of
human hepatocellular carcinoma were investigated optically
and compared with normal liver tissues. In hepatocellular
carcinoma, the sum of microsomal cytochromes P-450 and
P-420 per millgram of protein were almost the same as those
of the distant regions or normal liver tissues, but the ratios
of cytochrome P-450 to the sum of cytochrome P-450 and
P-420 were much lower in the microsomes of the hepato-
cellular carcinoma tissues than in normal liver microsomes,
although the microsomes from the cancer tissue and its distal
region were simultaneously prepared. The stability of cyto-
chrome P-450 molecules in cancer tiisues may be affected
by the abnormal protein structure of an abnormality of
the microsomal membranes.
In order to observe the instability of cytochrome P-450
molecules in whole tissues of the cancer, distant region and
normal liver, the electron paramagnetic resonance spectra
were measured at 15 K; typical spectra are shown in Figure
2. Judging from the signal height at g=2.25 for low spin
form and g=8.05 for high spin form, the cytochrome P-450
contents of whole tissues were decreased to about half in
hepatocellular carcinoma tissues compared to the normal
liver tissues. These differences in cytochrome P-450 contents
in normal and cancer tissues may be due to the changes of
circumstances of cytochrome P-450 molecules in cancer
tissues, because the sum of the concentrations of cyto-
chromes P-450 and P-420 in cancer tissues is almost compar-
able to that in the normal tissues spectrophotometrically.
The term 'circumstances' means the lipid composition of the
J
Figure 2 EPR spectra of human liver tissues of normal and
cancerous regions. The spectra were measured at 15K. Micro-
wave power, 5mW; modulation amplitude, 10G; scan speed,
625Gmin-1.
microsomal membrane, endogenous substrate, pH, micro-
somal membrane fluidity and electrolyte composition. Some
kinds of hepatocellular carcinoma tissues had a strong EPR
signal at g= 6.70 and weak EPR cytochrome P-450 signals at
other g values. This spectrum indicates that in certain kinds
of hepatocellular carcinoma, the rhombicity of the haem
moiety of cytochrome P-450 molecule may be changed; in
such cancer tissue, almost all cytochrome P-450 is irrever-10 I. HAMAMOTO et al.
sibly converted to cytochrome P-420. These results strongly
suggest that cytochrome P-450 of the cancer tissues is
already converted to the denatured form 'cytochrome P-420'
even in the intact cancer cells, although cytochrome P-420
gives various spin forms (Ichikawa & Yamano, 1970).
Activities of NADPH- and NADH-ferricyanide reductase
and NADPH- and NADH-cytochrome c reductase of each
kind of microsome were measured. In cancer microsomes,
ferricyanide reductase activities were the same as those in
normal microsomes, but cytochrome c reductase activities
were low. These findings suggest that in cancer microsomes
the electron can be easily transferred by the microsomal
cytochrome P-450-linked electron transport systems in
hepatocellular carcinoma tissues to smaller molecules such as
ferricyanide, but not to cytochrome c, and that the electron
transport efficiency is low. Thus, in the microsomal cyto-
chrome P-450-linked monooxygenase system, the electron
transport from NADH or NADPH to cytochrome P-450 is
impaired.
This property of microsomal cytochrome P-450-linked
monooxygenase systems in hepatocellular carcinoma tissues
may be explained by the following hypotheses: (1) abnormal
protein structure of the components of the monooxygenase
system; (2) aponisation of the components of cytochrome P-
450-linked monooxygenase system; and (3) abnormal struc-
tures and contents of the components of the microsomal
membranes.
The microsomes were analysed by the Western blotting
method with antibodies to cytochrome b5, NADH-
cytochrome b5 reductase or NADPH-cytochrome P-450
reductase. The concentrations were at the same levels in
normal and cancer microsomes. Their monomeric molecular
weights were the same. This indicates that in the cancer
microsomes apoenzymes of the microsomal monooxygenase
systems that cross-react with each antibody exist in equal
amounts. The concentration of cytochrome b5 measured by
Western blotting was less than the optical concentration.
This may be due to the affinity of the immune reaction of
the antibodies used in this experiment to human microsomal
cytochrome b5 being lower than its affinity to that of bovine
microsomes with which the antibodies were made. The
concentrations of NADPH-cytochrome P-450 reductase and
NADH-cytochrome b5 reductase measured by Western blot-
ting may also be lower than the real concentrations.
To examine hypothesis 3, the lipid compositions of
each kind of microsome were measured and the
phospholipid/cholesterol ratios were calculated. The concen-
trations of cholesterols per milligram of protein were
increased and those of phosphatidyl choline were decreased
in cancer microsomes, but the total phospholipid concen-
tration was not different. The cancer microsomes had lower
phospholipid/cholesterol ratios than those of other micro-
somes, and the microviscosity of the cancer microsomes may
be lower than that of normal microsomes (Kapitulnik et al.,
1987). Some membrane-bound enzymes, such as glucose-6-
phosphatase, UDP-glucuronyltransferase and calcium-
dependent ATPase, are unstable after treatment with phos-
pholipase A (Fiehn & Hasselbach, 1970). Strobel et al.
(1970) reported that the interaction between NADPH-
cytochrome P-450 reductase and cytochrome P-450 requires
the presence of phosphatidyl choline. The microsomal
cytochrome P-450-linked monooxygenase systems may
require the normal composition of phospholipids, especially
phosphatidyl choline, and cholesterols to transport electrons
efficiently. These results strongly support possibility 3 for the
low efficiency of electron transport in cancer microsomes.
In primary cancer of the mammalian liver, the activities of
both oxidative (phase I) and conjugative (phase II) enzymes
are decreased (El Mouelhi et al., 1987). In human liver
malignancies such as hepatocellular carcinoma, it seems that
the membrane lipid composition is different from that of
normal liver tissue. The difference may reduce the oxidative
and conjugative activities of the cancer.
The biochemical properties, including the concentrations
and activities of microsomal cytochrome P-450-linked
monooxygenase systems and microsomal lipid compositions
of the distant regions were not statistically different from
those of normal liver tissues except for the cholesterol
concentrations. Whether this difference has some meaning or
not remains to be investigated.
References
ASTROM, A., DEPIERRE, J.W. & ERIKSSON, L. (1983). Characteriza-
tion of drug metabolizing systems in hyperplastic nodules from
the livers of rats receiving 2-acetylaminofluorene in their diet.
Carcinogenesis, 4, 577.
BARENHOLZ, Y., PATZER, E.J., MOOR, N.F. & WAGNER, R.R.
(1978). Cholesterol oxidase as a probe for studying membrane
composition and organization. In Enzymes of Lipid Metabolism,
Gatt, S., Freysz, L. & Mandel, P. (eds) p. 45. Plenum Press: New
York.
BENGA, G., POP, V.I., IONESCU, M., HODARNAU, A., TILINCA, R. &
FRANGOPOL, P.T. (1983). Composition of human and rat liver
microsomes by spin label and biochemical analyses. Biochim.
Biophys. Acta, 750, 194.
BRADFORD, M.M. (1976). A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein-dye binding. Anal. Biochem., 72, 248.
COOPER, D.Y., LEVIN, S., NARASIMHULU, S., ROSENTHAL, 0. &
ESTABROOK, R.W. (1965). Photochemical action spectrum of the
terminal oxidase of mixed function oxidase systems. Science, 147,
400.
EL MOUELHI, M., DIDOLKAR, M.S., ELIAS, E.G., GUENGERICH,
F.P. & KAUFFMAN, F.C. (1987). Hepatic drug-metabolizing
enzymes in primary and secondary tumors of human liver.
Cancer Res., 47, 460.
ERIKSSON, L.C., TORNDAL, U.B. & ANDERSSON, G.N. (1983). Isola-
tion and characterization of endoplasmic reticulum and Golgi
apparatus from hepatocyte nodules in male Wistar rats. Cancer
Res., 43, 3335.
FARBE, E. (1984). The biochemistry of preneoplastic liver: A
common metabolic pattern in hepatocyte nodules. Can. J.
Biochem. Cell Biol., 62, 486.
FIEHN, W. & HASSELBACH, W. (1970). The effect of phospholipase
A on the calcium transport and the role of unsaturated fatty
acids in ATPase activity of sarcoplasmic vesicles. Eur. J.
Biochem., 13, 510.
FOLCH, J., LEES, M. & STANLEY, S. (1957). A simple method for the
isolation and purification of total lipids from animal tissues. J.
Biol. Chem., 226, 497.
HAMAMOTO, I., HIWATASHI, A. & ICHIKAWA, Y. (1986). Zonal
distribution of cytochrome P-450 and related enzymes of bovine
adrenal cortex - quantitative assay of concentrations and total
contents. J. Biochem., 99, 1743.
HIWATASHI, A., ICHIKAWA, Y., MARUYA, N., YAMANO, T. & AKI,
K. (1976). Properties of crystalline reduced nicotinamide adenine
dinucleotide phosphate-adrenodoxin reductase from bovine
adrenocortical mitochondria. I. Physiochemical properties of
holo- and apo-NADPH-adrenodoxin reductase and interaction
between non-heme iron proteins and the reductase. Biochemistry,
15, 3082.
HRYCAY, E.G. & PROUGH, R.A. (1974). Reduced nicotinamide
adenine dinucleotide-cytochrome b5 reductase and cytochrome b5
as electron carriers in NADH-supported cytochrome P-450-
dependent enzyme activities in liver microsomes. Arch. Biochem.
Biophys., 165, 331.
ICHIKAWA, Y. & YAMANO, T. (1970). Preparation and physico-
chemical properties of functional hemoprotein P-450 from mam-
malian tissue microsomes. Biochim. Biophys. Acta, 200, 220.
ICHIKAWA, Y., HAGIHARA, B. & YAMANO, T. (1967). Magnetic and
spectrophotometric properties of the microsomal CO-binding
pigment. Arch. Biochem. Biophys., 120, 204.HUMAN HEPATOCELLULAR CARCINOMA 11
IYANAGI, T. & MASON, H.S. (1973). Some properties of hepatic
reduced nicotinamide adenine dinucleotide phosphate-
cytochrome c reductase. Biochemistry, 12, 2297.
KADUCE, T.L., NORTON, K.C. & SPECTOR, A.A. (1983). A rapid,
isocratic method for phospholipid separation by high-
performance liquid chromatography. J. Lipid. Res., 24, 1398.
KAPITULNIK, J., WEIL, E., RABINOWITZ, R. & KRAUSZ, M.M.
(1987). Fetal and adult human liver differ markedly in the
fluidity and lipid composition of their microsomal membranes.
Hepatology, 7, 55.
LAEMMLI, U.K. (1970). Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature, 227, 680.
MASON, H.S., YAMANO, T., NORTH, J.C., HASHIMOTO, Y. &
SAKAGISHI, P. (1965). In Oxidases and Related Redox Systems,
Vol. 2, King, T., Mason, H.S. & Morrison, M. (eds) p. 879.
Wiley: Chichester.
NORMAN, R.L., MULLER-EBERHARD, U. & JOHNSON, E.F. (1979).
The role of cytochrome P-450 forms in 2-aminoanthracene and
benzo(a)pyrene mutagenesis. Biochem. Biophys. Res. Commun.,
89, 195.
OMURA, T. & SATO, R. (1964a). The carbon monoxide-binding
pigment of liver microsomes. J. Biol. Chem., 239, 2370.
OMURA, T. & SATO, R. (1964b). The carbon monoxide-binding
pigment of liver microsomes. J. Biol. Chem., 239, 2379.
OPRIAN, D.D. & COON, M.J. (1982). Oxidation-reduction states of
FMN and FAD in NADPH-cytochrome P-450 reductase during
reduction by NADPH. J. Biol. Chem., 257, 8935.
SPATZ, L. & STRITrMATTER, P. (1973). A form of reduced nicoti-
namide adenine dinucleotide-cytochrome b5 reductase containing
both the catalytic site and an additional hydrophobic membrane-
binding segment. J. Biol. Chem., 248, 793.
STROBEL, H.W., LU, A.Y., HEIDEMA, J. & COON, M.J. (1970).
Phosphatidylcholine requirement in the enzymatic reduction of
hemoprotein P-450 and in fatty acid, hydrocarbon, and drug
hydroxylation. J. Biol. Chem., 245, 4851.
WANG, P.P., BEAUNE, P., KAMINSKY, L.S. & 4 others (1983).
Purification and characterization of six cytochrome P-450
isoenzymes from human liver microsomes. Biochemistry, 22,
5375.
WASKELL, L., KOBLIN, D. & CANOVA-DAVIS, E. (1982). The lipid
composition of human liver microsomes. Lipids, 17, 317.
WRIGHTON, S.A., CAMPANILE, C., THOMAS, P.E. & 8 others (1986).
Identification of a human liver cytochrome P-450 homologous to
the major isosafrole-inducible cytochrome P-450 in the rat. Mol.
Pharmacol., 29, 405.